beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Term ID

CHEBI:71341

Synonyms

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-[2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-alpha-D-galactopyranose
beta-D-GlcNAc-(1->3)-[beta-D-GlcNAc-(1->6)]-alpha-D-GalNAc
GlcNAcb1-3(GlcNAcb1-6)GalNAca
GlcNAcb1-6(GlcNAcb1-3)GalNAca
GlcNAcbeta1-3(GlcNAcbeta1-6)GalNAcalpha
GlcNAcbeta1-6(GlcNAcbeta1-3)GalNAcalpha
N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosamine
O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)]-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose

Definition

A branched amino trisaccharide comprising an N -acetyl-α-D-galactosamine residue at the reducing end, to which are (1→3)- and (1→6)-linked two N -acetyl-α-D-glucosamine residues.

References

glygen:G00037MO
glytoucan:G00037MO
pubmed:19443021
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype affecting beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Human Disease Model